Bitcoin

The event highlights the growing intersection of biotech and crypto via decentralized science (DeSci) and tokenized biotech assets, but mainstream crypto remains driven by macro liquidity and ETF flows. With BTC dominance high, altcoins—including DeSci tokens—are likely to underperform unless a sector-specific catalyst emerges.

A modified medication targeting cells implicated in endometriosis lesions shows early promise in research, according to a Nature article.